The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors (RF) for poor outcomes in esophageal (EC) and gastric (GC) adenocarcinomas treated with immune-checkpoint inhibitors (ICI).
 
Eric Min
No Relationships to Disclose
 
Katherine K Benson
No Relationships to Disclose
 
Samuel Paul
No Relationships to Disclose
 
Menglin Xu
No Relationships to Disclose
 
Anne M. Noonan
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I); Deciphera (I); Eisai; Exelixis; GOG Foundation (I); Helsinn Healthcare; Immunogen (I); Merck (I); OncLive/MJH Life Sciences; OncLive/MJH Life Sciences (I); QED Therapeutics
 
Arjun Mittra
Stock and Other Ownership Interests - Merck (I)
 
Pannaga G. Malalur
No Relationships to Disclose
 
Sameek Roychowdhury
No Relationships to Disclose
 
Ning Jin
No Relationships to Disclose
 
John L. Hays
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Deciphera; Ipsen; Merck; Mersana; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Merck; Tesaro
 
Rifat T. Elkhatib
No Relationships to Disclose
 
Shafia Rahman
No Relationships to Disclose
 
Eric David Miller
Research Funding - EMD Serono
Other Relationship - NCCN
 
Dayssy Alexandra Diaz Pardo
No Relationships to Disclose
 
Ashish Manne
No Relationships to Disclose